Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment sector : Mining, quarrying, and oil and gas extraction save search
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
Published: 2024-01-03 (Crawled : 12:00) - xortx.com
XRTX | $3.5 -3.05% -3.14% 12K
|
Mining, Quarrying, and Oil and ...
|
| O: 6.59%
H: 27.08%
C: 6.18%
disease kidney treatment
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
PRTG | $0.221 -21.35% -27.15% 270K
|
Mining, Quarrying, and Oil and ...
|
| O: 2.47%
H: 17.65%
C: 0.8%
lung melanoma biotech cancer cell treatment meeting trial
Gas Separation Membranes Market Report 2022: Technological Innovations in Water and Wastewater Treatments Bolsters Growth
Published: 2023-01-27 (Crawled : 14:00) - prnewswire.com
ATLPF | $17.205 -26.89% 540
|
n/a
|
| O: -2.87%
H: 0.0%
C: 0.0%
ATLCY | $14.72 -2.81% 19K
|
Manufacturing
|
| O: -3.1%
H: 1.79%
C: 1.13%
MITUY | $14.65 -19.3% 110
|
Mining, Quarrying, and Oil and ...
|
| O: 0.66%
H: 0.72%
C: 0.72%
ATLKY | $16.77 -11.01% 4.3M
|
Manufacturing
|
| O: -2.97%
H: 1.96%
C: 1.79%
water report growth market
AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma – Yahoo Finance
Published: 2023-01-05 (Crawled : 13:20) - spacfeed.com
LTUM | $0.0347 33.16% 180K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 0.21%
C: -4.76%
aum302 treatment fda rare designation disease
UroGen Announces New Data from the OLYMPUS Trial that Shows Median Durability of Response of 28.9 Months for JELMYTO®, the Only Non-Surgical, Chemoablative Treatment for Adults with Low-Grade Upper Tra...
Published: 2022-12-02 (Crawled : 13:00) - biospace.com/
WDH | $1.24 2.48% -0.81% 220K
|
Finance and Insurance
|
| O: -3.09%
H: 6.37%
C: 2.55%
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
|
| O: -0.55%
H: 0.64%
C: 0.09%
URGN | $14.27 -1.52% -1.54% 180K
|
Health Technology
|
| O: -1.49%
H: 3.84%
C: -2.44%
SNDX | $20.75 -2.49% -2.55% 1.7M
|
Health Technology
|
| O: -0.16%
H: 1.12%
C: 0.32%
GTHX | News | $4.28 4.9% 4.67% 690K
|
Health Technology
|
| O: -2.22%
H: 9.27%
C: 7.69%
ACET | $2.26 3.2% 3.1% 760K
|
Health Technology
|
| O: -1.13%
H: 5.01%
C: 4.84%
jelmyto treatment trial response
Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2 for the Treatment of Melanoma and Non-Small Cell Lung Cancer (NSCLC)
Published: 2021-08-05 (Crawled : 12:00) - globenewswire.com
PRTG | $0.221 -21.35% -27.15% 270K
|
Mining, Quarrying, and Oil and ...
|
| O: 1.25%
H: 13.6%
C: 12.88%
treatment lung cancer cancer biotech iot
Portage Biotech Highlights First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors
Published: 2021-04-08 (Crawled : 15:00) - biospace.com/
PRTG | $0.221 -21.35% -27.15% 270K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 2.26%
C: -3.87%
treatment solid tumors positive biotech iot
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.